Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Dyspnea × Sugars × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 13 cyclopia sequence 7 Neoplasms 6 Prostatic Neoplasms 5 Lung Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Polycystic Ovary Syndrome 3 Pain 3 Neoplasm Metastasis 3 Multiple Myeloma 3 Fatigue 3 Vomiting 2 Urinary Bladder Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Obesity 2 Neoplasms, Plasma Cell 2 Nausea 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma 2 Leiomyoma 2 Hematologic Diseases 2 Head and Neck Neoplasms 2 Burkitt Lymphoma 2 Weight Loss 1 Warts 1 Vitamin D Deficiency 1 Tobacco Use Cessation 1 Testicular Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1

Interventions

Surveys and Questionnaires 4 Dexamethasone 2 Calcium Dobesilate 2 Acupuncture Therapy 2 dexamethasone acetate 1 dexamethasone 21-phosphate 1 auricularum 1 Tiotropium Bromide 1 Sugars 1 Standard of Care 1 Rehabilitation 1 Oxygen 1 Midazolam 1 Losartan 1 Lisinopril 1 Hypnosis 1 Hematologic Tests 1 Furosemide 1 Exercise 1 Echocardiography 1 Dexmedetomidine 1 Buspirone 1 Behavior Therapy 1 Aromatherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01670097 2021-02-17

Dexamethasone Dyspnea Study

M.D. Anderson Cancer Center

Phase 2 Completed

52 enrolled 13 charts

Dyspnea, Hematologic Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡